Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...
Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to ...
Owkin, an AI company on a mission to solve the complexity of biology, today announced that its interoperable Pathology ...
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new ...
Engineers at the University of California have developed a new data structure and compression technique that enables the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback